Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04248127

The Influence of Honey-flavored Yogurt on Low-grade Inflammation and Gut Health in Middle to Older Aged Women.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
University of California, Davis · Academic / Other
Sex
Female
Age
45 Years – 65 Years
Healthy volunteers
Accepted

Summary

A randomized, double-blind, crossover dietary intervention trial will test the effects of 4 weeks of daily honey-flavored yogurt intake on markers of inflammation (Th17 cytokines) and oxidative stress (NOX2, UA, RSNO) and associative changes with microbial derived metabolites (SCFAs, BAs, ellagitannins), metabolism and the fecal microbiome. The above suite of selected markers will capture diet-induced systemic changes in inflammation and oxidative stress, while assessing associated microbial changes.

Detailed description

Those qualified for enrollment will be randomized into a double-blind crossover study to consume 2 morning servings of a 0.6 cup (150g) of plain yogurt with : A) cane sugar added in an isocaloric level as the honey or, B) 1 tbsp of phenolic-rich honey for 4 weeks. A one-month washout between periods will be used. The participants will be instructed to consume one yogurt in replacement of or as part of breakfast, and as a late morning snack. They will also be instructed to not add any additional items to the yogurt. Therefore, each study participant will consume 2 tbsp. of honey a day for four weeks, which is a realistic amount typically consumed by honey users.

Conditions

Interventions

TypeNameDescription
OTHERHoney sweetened yogurt2 tbsp. of daily honey intake in 1.2 cups of yogurt per day, split into two equal portions
OTHERSugar sweetened yogurtsugar added, in an isocaloric fashion to the honey, to 1.2 cups of yogurt per day, split into two equal portions

Timeline

Start date
2021-11-01
Primary completion
2026-07-25
Completion
2026-07-31
First posted
2020-01-30
Last updated
2026-02-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04248127. Inclusion in this directory is not an endorsement.